[1P] Poster Presentation 1

[1P-873] DOT1L inhibition reprograms innate immunity signaling to potentiate immunomodulatory drug responses in multiple myeloma

○Kazuya Ishiguro^1,2, Hiroshi Kitajima¹, Takeshi Niinuma¹, Reo Maruyama³, Tomohide Tsukahara⁴, Yoshihiko Hirohashi⁴, Kohei Kumegawa⁵, Masahiro Kai¹, Hiroshi Nakase², Hiromu Suzuki¹ (1. Div. Mol. Biol., Dept. Biochem., Sapporo Med. Univ., Sch. Med., 2. Div. Gastroenterol. Hepatol., Dept. Int. Med., Sapporo Med. Univ., Sch. Med., 3. Dept. Cancer Epigenome, Cancer Inst., Japanese Found. Cancer, 4. Div. 1st Pathol., Dept. Pathol., Sapporo Med. Univ., Sch. Med., 5. Next-Ganken program, Cancer Inst., Japanese Found. Cancer)